Correction to: Drug therapy and catheter ablation for management of arrhythmias in continuous flow left ventricular assist device's patients: a Clinical Consensus Statement of the European Heart Rhythm Association and the Heart Failure Association of the ESC
- PMID: 40401315
- PMCID: PMC12096001
- DOI: 10.1093/europace/euaf086
Correction to: Drug therapy and catheter ablation for management of arrhythmias in continuous flow left ventricular assist device's patients: a Clinical Consensus Statement of the European Heart Rhythm Association and the Heart Failure Association of the ESC
Erratum for
-
Drug therapy and catheter ablation for management of arrhythmias in continuous flow left ventricular assist device's patients: a Clinical Consensus Statement of the European Heart Rhythm Association and the Heart Failure Association of the ESC.Europace. 2024 Nov 1;26(11):euae272. doi: 10.1093/europace/euae272. Europace. 2024. PMID: 39478667 Free PMC article.
Similar articles
-
Drug therapy and catheter ablation for management of arrhythmias in continuous flow left ventricular assist device's patients: a Clinical Consensus Statement of the European Heart Rhythm Association and the Heart Failure Association of the ESC.Europace. 2024 Nov 1;26(11):euae272. doi: 10.1093/europace/euae272. Europace. 2024. PMID: 39478667 Free PMC article.
-
Device Therapy and Arrhythmia Management in Left Ventricular Assist Device Recipients: A Scientific Statement From the American Heart Association.Circulation. 2019 May 14;139(20):e967-e989. doi: 10.1161/CIR.0000000000000673. Circulation. 2019. PMID: 30943783
-
The diagnostic role of pharmacological provocation testing in cardiac electrophysiology: a clinical consensus statement of the European Heart Rhythm Association and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC, the ESC Working Group on Cardiovascular Pharmacotherapy, the Association of European Paediatric and Congenital Cardiology (AEPC), the Paediatric & Congenital Electrophysiology Society (PACES), the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), and the Latin American Heart Rhythm Society (LAHRS).Europace. 2025 Mar 28;27(4):euaf067. doi: 10.1093/europace/euaf067. Europace. 2025. PMID: 40165484 Free PMC article.
-
2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society.Heart Rhythm. 2012 Apr;9(4):632-696.e21. doi: 10.1016/j.hrthm.2011.12.016. Epub 2012 Mar 1. Heart Rhythm. 2012. PMID: 22386883 No abstract available.
-
Atrial fibrillation catheter ablation: an updated review of current guidelines and expert consensus documents.Herzschrittmacherther Elektrophysiol. 2019 Dec;30(4):371-376. doi: 10.1007/s00399-019-00651-0. Epub 2019 Nov 15. Herzschrittmacherther Elektrophysiol. 2019. PMID: 31729548 Review. English.
Publication types
LinkOut - more resources
Full Text Sources